| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |